Prognostic Role of Programmed Death Ligand-1 Expression in Breast Cancer: A Systematic Review and Meta-Analysis
作者： Xue Li , Minghuan Li , Zhen Lian , Hui Zhu , Li Kong
DOI: 10.1007/S11523-016-0451-8
关键词:
摘要: Background Cancer therapies that target the PD-1/PD-L1 pathway are in ongoing phase I/II clinical trials for several tumor types. However, prognostic value of PD-L1 expression breast cancer is unclear.
springer.com
sci-hub.se 参考文章(52)
Dallas B. Flies, Mario Sznol, Lieping Chen, Britt J. Sandler, Blockade of the B7-H1/PD-1 Pathway for Cancer Immunotherapy Yale Journal of Biology and Medicine. ,vol. 84, pp. 409- 421 ,(2011)
Leisha A. Emens, Fadi S. Braiteh, Philippe Cassier, Jean-Pierre Delord, Joseph Paul Eder, Marcella Fasso, Yuanyuan Xiao, Yan Wang, Luciana Molinero, Daniel S. Chen, Ian Krop, Abstract 2859: Inhibition of PD-L1 by MPDL3280A leads to clinical activity in patients with metastatic triple-negative breast cancer (TNBC) Cancer Research. ,vol. 75, pp. 2859- 2859 ,(2015) , 10.1158/1538-7445.AM2015-2859
Ninh M. La-Beck, Gary W. Jean, Cindy Huynh, Saeed K. Alzghari, Devin B. Lowe, Immune Checkpoint Inhibitors: New Insights and Current Place in Cancer Therapy Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. ,vol. 35, pp. 963- 976 ,(2015) , 10.1002/PHAR.1643
Kathleen M. Mahoney, Gordon J. Freeman, David F. McDermott, The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma Clinical Therapeutics. ,vol. 37, pp. 764- 782 ,(2015) , 10.1016/J.CLINTHERA.2015.02.018
Michael R. Green, Stefano Monti, Scott J. Rodig, Przemyslaw Juszczynski, Treeve Currie, Evan O'Donnell, Bjoern Chapuy, Kunihiko Takeyama, Donna Neuberg, Todd R. Golub, Jeffery L. Kutok, Margaret A. Shipp, Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma Blood. ,vol. 116, pp. 3268- 3277 ,(2010) , 10.1182/BLOOD-2010-05-282780
Hazem Ghebeh, Shamayel Mohammed, Abeer Al-Omair, Amal Qattant, Cynthia Lehe, Ghofran Al-Qudaihi, Naser Elkum, Mohamed Alshabanah, Suad Bin Amer, Asma Tulbah, Dahish Ajarim, Taher Al-Tweigeri, Said Dermime, The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors. Neoplasia. ,vol. 8, pp. 190- 198 ,(2006) , 10.1593/NEO.05733
Jennifer M. Bordeaux, Huan Cheng, Allison W. Welsh, Bruce G. Haffty, Donald R. Lannin, Xingyong Wu, Nan Su, Xiao-Jun Ma, Yuling Luo, David L. Rimm, Quantitative In Situ Measurement of Estrogen Receptor mRNA Predicts Response to Tamoxifen PLOS ONE. ,vol. 7, ,(2012) , 10.1371/JOURNAL.PONE.0036559
Alessandro Liberati, The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration Annals of Internal Medicine. ,vol. 151, pp. W- ,(2009) , 10.7326/0003-4819-151-4-200908180-00136
Sue Duval, Richard Tweedie, Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. ,vol. 56, pp. 455- 463 ,(2000) , 10.1111/J.0006-341X.2000.00455.X
Vamsidhar Velcheti, Kurt A Schalper, Daniel E Carvajal, Valsamo K Anagnostou, Konstantinos N Syrigos, Mario Sznol, Roy S Herbst, Scott N Gettinger, Lieping Chen, David L Rimm, Programmed death ligand-1 expression in non-small cell lung cancer. Laboratory Investigation. ,vol. 94, pp. 107- 116 ,(2014) , 10.1038/LABINVEST.2013.130